VQLA — VOQUZ Labs AG Income Statement
0.000.00%
Last trade - 00:00
- €5.25m
- €6.39m
- €3.80m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 1.78 | 2.21 | 3.14 | 3.8 |
Cost of Revenue | ||||
Gross Profit | 1.29 | 1.78 | 2.48 | 2.97 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 1.81 | 1.88 | 2.68 | 3.3 |
Operating Profit | -0.026 | 0.329 | 0.461 | 0.506 |
Net Income Before Taxes | -0.026 | 0.329 | 0.461 | 0.506 |
Provision for Income Taxes | ||||
Net Income After Taxes | -0.065 | 0.326 | 0.314 | 0.358 |
Net Income Before Extraordinary Items | ||||
Net Income | -0.065 | 0.326 | 0.314 | 0.358 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -0.065 | 0.326 | 0.314 | 0.358 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.065 | 0.323 | 0.299 | 0.341 |
Dividends per Share |